BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9376343)

  • 1. Gossypol modification of Ala-1 of secreted phospholipase A2: a probe for the kinetic effects of sulfate glycoconjugates.
    Yu BZ; Rogers J; Ranadive G; Baker S; Wilton DC; Apitz-Castro R; Jain MK
    Biochemistry; 1997 Oct; 36(41):12400-11. PubMed ID: 9376343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic and kinetic basis of interfacial activation: resolution of binding and allosteric effects on pancreatic phospholipase A2 at zwitterionic interfaces.
    Berg OG; Rogers J; Yu BZ; Yao J; Romsted LS; Jain MK
    Biochemistry; 1997 Nov; 36(47):14512-30. PubMed ID: 9398170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase A2 engineering. Deletion of the C-terminus segment changes substrate specificity and uncouples calcium and substrate binding at the zwitterionic interface.
    Huang B; Yu BZ; Rogers J; Byeon IJ; Sekar K; Chen X; Sundaralingam M; Tsai MD; Jain MK
    Biochemistry; 1996 Sep; 35(37):12164-74. PubMed ID: 8810924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of human group IIa secreted phospholipase A2 on cell membranes. Vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme.
    Koduri RS; Baker SF; Snitko Y; Han SK; Cho W; Wilton DC; Gelb MH
    J Biol Chem; 1998 Nov; 273(48):32142-53. PubMed ID: 9822691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic and structural properties of disulfide engineered phospholipase A2: insight into the role of disulfide bonding patterns.
    Yu BZ; Pan YH; Janssen MJ; Bahnson BJ; Jain MK
    Biochemistry; 2005 Mar; 44(9):3369-79. PubMed ID: 15736947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of the chemical step by leucine-31 of pancreatic phospholipase A2.
    Yu BZ; Janssen MJ; Verheij HM; Jain MK
    Biochemistry; 2000 May; 39(19):5702-11. PubMed ID: 10801320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase A2 at the bilayer interface.
    Ramirez F; Jain MK
    Proteins; 1991; 9(4):229-39. PubMed ID: 1866429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The divalent cation is obligatory for the binding of ligands to the catalytic site of secreted phospholipase A2.
    Yu BZ; Berg OG; Jain MK
    Biochemistry; 1993 Jun; 32(25):6485-92. PubMed ID: 8518290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of monodisperse anionic amphiphiles with the i-face of secreted phospholipase A2.
    Yu BZ; Apitz-Castro R; Tsai MD; Jain MK
    Biochemistry; 2003 May; 42(20):6293-301. PubMed ID: 12755634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of interfacial equilibria to interfacial activation of phospholipase A2.
    Jain MK; Yu BZ; Berg OG
    Biochemistry; 1993 Oct; 32(42):11319-29. PubMed ID: 8043052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of surface hydrophobic residues in the interfacial catalysis of bovine pancreatic phospholipase A2.
    Lee BI; Yoon ET; Cho W
    Biochemistry; 1996 Apr; 35(13):4231-40. PubMed ID: 8672459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of the anionic interface preference and kcat* activation of pancreatic phospholipase A2.
    Yu BZ; Poi MJ; Ramagopal UA; Jain R; Ramakumar S; Berg OG; Tsai MD; Sekar K; Jain MK
    Biochemistry; 2000 Oct; 39(40):12312-23. PubMed ID: 11015210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic residues 53 and 56 control the anion-induced interfacial k*cat activation of pancreatic phospholipase A2.
    Rogers J; Yu BZ; Tsai MD; Berg OG; Jain MK
    Biochemistry; 1998 Jun; 37(26):9549-56. PubMed ID: 9649338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of arg-30 as the essential residue for the enzymatic activity of Taiwan cobra phospholipase A2.
    Chang LS; Lin SR; Chang CC
    J Biochem; 1998 Oct; 124(4):764-8. PubMed ID: 9756621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human secretory phospholipase A2: purification and characterization of the enzyme for active site studies.
    Stadel JM; Jones C; Livi GP; Hoyle K; Kurdyla J; Roshak A; McLaughlin MM; Pfarr DA; Comer S; Strickler J
    J Mol Recognit; 1992 Dec; 5(4):145-53. PubMed ID: 1339483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five coplanar anion binding sites on one face of phospholipase A2: relationship to interface binding.
    Pan YH; Epstein TM; Jain MK; Bahnson BJ
    Biochemistry; 2001 Jan; 40(3):609-17. PubMed ID: 11170377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the interfacial binding surface of human secretory group IIa phospholipase A2.
    Snitko Y; Koduri RS; Han SK; Othman R; Baker SF; Molini BJ; Wilton DC; Gelb MH; Cho W
    Biochemistry; 1997 Nov; 36(47):14325-33. PubMed ID: 9398150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of residues of pancreatic phospholipase A2 to interfacial binding, catalysis, and activation.
    Yu BZ; Rogers J; Tsai MD; Pidgeon C; Jain MK
    Biochemistry; 1999 Apr; 38(15):4875-84. PubMed ID: 10200177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desolvation map of the i-face of phospholipase A2.
    Tsai YC; Yu BZ; Wang YZ; Chen J; Jain MK
    Biochim Biophys Acta; 2006 May; 1758(5):653-65. PubMed ID: 16730646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for bile salt inhibition of pancreatic phospholipase A2.
    Pan YH; Bahnson BJ
    J Mol Biol; 2007 Jun; 369(2):439-50. PubMed ID: 17434532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.